欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2687 条，共 135 页，当前第 8 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Siiltibcy Human Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10) Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10) EMEA/H/C/006177 Serum Life Science Europe GmbH 2025/01/13 Authorised
Augtyro Human repotrectinib repotrectinib EMEA/H/C/006005 Bristol-Myers Squibb Pharma EEIG 2025/01/13 Authorised
Buprenorphine Neuraxpharm Human buprenorphine buprenorphine hydrochloride EMEA/H/C/006188 Neuraxpharm Pharmaceuticals S.L. 2024/12/19 Authorised
Alhemo Human concizumab concizumab EMEA/H/C/005938 Novo Nordisk A/S 2024/12/13 Authorised
Imuldosa Human ustekinumab ustekinumab EMEA/H/C/006221 Accord Healthcare S.L.U. 2024/12/12 Authorised
Eltrombopag Viatris Human eltrombopag eltrombopag olamine EMEA/H/C/006417 Viatris Limited 2024/12/12 Authorised
Absimky Human ustekinumab ustekinumab EMEA/H/C/006585 Accord Healthcare S.L.U. 2024/12/12 Withdrawn
Theralugand Human lutetium (177Lu) chloride lutetium (177Lu) chloride EMEA/H/C/005882 Eckert & Ziegler Radiopharma GmbH 2024/11/22 Authorised
Hympavzi Human marstacimab marstacimab EMEA/H/C/006240 Pfizer Europe MA EEIG 2024/11/18 Authorised
Flucelvax Human influenza vaccine (surface antigen, inactivated, prepared in cell cultures) A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167) / A/District of Columbia/27/2023 (H3N2)-like strain (A/Victoria/800/2024 CVR-289) / B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021) EMEA/H/C/006532 Seqirus Netherlands B.V. 2024/11/15 Authorised
Fluad Human influenza vaccine (surface antigen, inactivated, adjuvanted) A/Victoria/4897/2022 (H1N1)pdm09 like strain (A/Victoria/4897/2022, IVR-238);A/Croatia/10136RV/2023 (H3N2)-like strain (A/Croatia/10136RV/2023, X-425A);B/Austria/1359417/2021 like strain (B/Austria/1359417/2021, BVR-26) EMEA/H/C/006538 Seqirus Netherlands B.V. 2024/11/15 Authorised
Pomalidomide Teva Human pomalidomide Pomalidomide EMEA/H/C/006302 Teva GmbH 2024/11/14 Authorised
Elahere Human mirvetuximab soravtansine mirvetuximab soravtansine EMEA/H/C/005036 AbbVie Deutschland GmbH & Co. KG 2024/11/14 Authorised
Penbraya Human meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed) Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group B fHBP protein subfamily A;Neisseria meningitidis group B fHBP protein subfamily B EMEA/H/C/006165 Pfizer Europe MA EEIG 2024/11/14 Withdrawn
Afqlir Human aflibercept aflibercept EMEA/H/C/006150 Sandoz GmbH 2024/11/13 Authorised
Opuviz Human aflibercept aflibercept EMEA/H/C/006056 Samsung Bioepis NL B.V. 2024/11/13 Authorised
Yuvanci Human macitentan;tadalafil macitentan;tadalafil EMEA/H/C/005001 Janssen-Cilag International NV 2024/09/27 Authorised
Otulfi Human ustekinumab ustekinumab EMEA/H/C/006544 Fresenius Kabi Deutschland GmbH 2024/09/25 Authorised
Fymskina Human ustekinumab ustekinumab EMEA/H/C/005805 Formycon AG 2024/09/25 Authorised
Loqtorzi Human toripalimab toripalimab EMEA/H/C/006120 Topalliance Biosciences Europe Limited 2024/09/19 Authorised

数据库说明：

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase